What is NDC 73153-900?

73153-900 is the product NDC for Breyanzi (lisocabtagene maraleucel) kit, listed with the FDA by Juno Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Breyanzi (Lisocabtagene maraleucel).

Juno Therapeutics, Inc., NDC labeler code 73153. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Breyanzi?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Breyanzi NDC 73153-900 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73153-900Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73153-0900Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73153-900-01	73153090001	1 KIT in 1 CARTON (73153-900-01) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-902-04) * 5 mL in 1 VIAL, SINGLE-DOSE (73153-901-08)Marketed from Feb 5, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Breyanzi
Generic name (nonproprietary): lisocabtagene maraleucel
Dosage form: Kit
Labeler: Juno Therapeutics, Inc.NDC labeler code 73153
Product type: Cellular therapy
Marketing category: BLA — Biologics License ApplicationApplication BLA 125714
Marketing start: Feb 5, 2021
Listing expires: Dec 31, 2027
Identifiers: Product ID 73153-900_6e83a5e5-a286-42e0-b22b-7d5f0b2cb920SPL ID 6e83a5e5-a286-42e0-b22b-7d5f0b2cb920SPL set ID 594bb413-af3b-4b97-afb3-bfe2b174f2edRxCUI 2479140, 2479145

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N473153090001 followed by a unit qualifier and the quantity

Package 73153-0900-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 20, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

BREYANZI is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of: • adult patients with large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B, who have: • refractory disease to first-line chemoimmunotherapy or relapse within 12 months of first-line chemoimmunotherapy; or • refractory disease to first-line chemoimmunotherapy or relapse after first-line chemoimmunotherapy and are not eligible for hematopoietic stem cell transplantation (HSCT) due to…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73153-900

What is NDC 73153-900?: 73153-900 is the product NDC for Breyanzi (lisocabtagene maraleucel) kit, listed with the FDA by Juno Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Breyanzi (Lisocabtagene maraleucel).
Who is the labeler?: Juno Therapeutics, Inc., NDC labeler code 73153. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Breyanzi?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Breyanzi (Lisocabtagene maraleucel) NDC 73153-900